WeVote
Log In

Bill

Bill

H 5040

An Act relative to PANDAS/PANS screening in medical/clinical settings

194th Legislature (2025-2026) Introduced by Jamie Eldridge and 7 co-sponsors

Requires Massachusetts healthcare providers to implement standardized PANDAS/PANS screening protocols for children with acute psychiatric symptoms to improve early identification and treatment access.

Reporting date extended to Thursday, December 31, 2026
0
WeVote Research Nonpartisan
Bill Summary · H 5040

Legislative bill overview

H 5040 mandates screening and clinical protocols for PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections) and PANS (Pediatric Acute-onset Neuropsychiatric Syndrome) in Massachusetts medical and clinical settings. The bill requires healthcare providers to implement standardized screening procedures and establish diagnostic guidelines for these conditions, which present with sudden-onset psychiatric and neurological symptoms in children.

Why is this important

PANDAS/PANS cases can be severely disabling, causing rapid deterioration in functioning, and early identification may improve treatment outcomes. Currently, there is significant variability in how clinicians recognize and diagnose these conditions, potentially leading to delayed care, misdiagnosis, and inappropriate treatment. Standardized screening could reduce diagnostic gaps and ensure affected children receive timely intervention.

Potential points of contention

  • Medical consensus concerns: While PANDAS has gained recognition, some medical organizations (including portions of the infectious disease community) maintain that evidence for the condition remains limited compared to established diagnoses, raising questions about mandatory screening protocols
  • Implementation costs and burden: Requiring comprehensive screening across all medical settings may strain healthcare resources, particularly in primary care practices, without clear reimbursement mechanisms specified
  • Diagnostic specificity: PANS/PANDAS symptoms overlap significantly with other pediatric psychiatric conditions, OCD, and autoimmune encephalitis; mandatory screening could increase false positives and unnecessary specialist referrals without clear clinical pathways

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.